Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;36(2):201-5.
doi: 10.1165/rcmb.2006-0269TR. Epub 2006 Sep 21.

Lipid mediators as agonists for the resolution of acute lung inflammation and injury

Affiliations
Review

Lipid mediators as agonists for the resolution of acute lung inflammation and injury

Caroline Bonnans et al. Am J Respir Cell Mol Biol. 2007 Feb.

Abstract

Resolution of acute lung inflammation and injury is an active process; it is not merely the absence of proinflammatory signals. Restoration of homeostasis is coordinated by specific mediators and cellular events. In response to injury and inflammatory stimuli, infiltrating leukocytes and tissue-resident cells interact to generate lipoxins (LXs), which are bioactive eicosanoids derived from arachidonic acid. In contrast to proinflammatory leukotrienes and prostaglandins, LXs display potent antiinflammatory actions. LXA(4) interacts with a G protein-coupled receptor, termed ALX, that transduces counter-regulatory signals in part via intracellular polyisoprenyl phosphate remodeling. Presqualene diphosphate (PSDP) is a polyisoprenyl phosphate in human neutrophils that is rapidly converted to presqualene monophosphate (PSMP) upon cell activation. PSDP, but not PSMP, directly inhibits phospholipase D, phosphoinositol-3 kinase, and superoxide anion generation. LXs block PSDP turnover in neutrophil membranes to prevent proinflammatory responses. Hence, LX and polyisoprenyl phosphate signaling provide a counter-regulatory circuit to promote resolution of acute lung inflammation. LXA(4) and PSDP mimetics have been prepared with potent protective actions in murine models of asthma and acute lung injury.

PubMed Disclaimer

Figures

<b>Figure 1.</b>
Figure 1.
Polyisoprenyl phosphate remodeling. PMN activation by G-protein–coupled (LTB4, formyl-methionyl-leucyl-phenylalanine) and growth factor (granulocyte monocyte colony-stimulating factor) receptors can trigger PSDP remodeling to PSMP.
<b>Figure 2.</b>
Figure 2.
Polyisoprenyl phosphate remodeling in PMN: a rapid signaling pathway engaged during LX–ALX interactions. LXA4 and 15-epi-LXA4 are produced during inflammation as “stop signals” for agonist-triggered PMN responses. Interactions with ALX block agonist-induced PSDP turnover to PSMP. PSDP inhibits PLD and PI3K to reduce prophlogistic cellular responses.
<b>Figure 3.</b>
Figure 3.
Resolution of acute lung inflammation by LXs. Acid aspiration is a common cause of ALI. During host responses to injury, LXs are generated locally to block PMN transmigration and activation, decrease edema and leakage of plasma proteins into the airways, promote restitution of injured airway epithelium, and block cytokine and chemokine release.

References

    1. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334–1349. - PubMed
    1. Nathan C. Points of control in inflammation. Nature 2002;420:846–852. - PubMed
    1. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution. Prostaglandins Leukot Essent Fatty Acids 2005;73:141–162. - PubMed
    1. Bernard GR, Korley V, Chee P, Swindell B, Ford-Hutchinson AW, Tagari P. Persistent generation of peptido leukotrienes in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1991;144:263–267. - PubMed
    1. Goldman G, Welbourn R, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Synergism between leukotriene B4 and thromboxane A2 in mediating acid-aspiration injury. Surgery 1992;111:55–61. - PubMed

Publication types

MeSH terms